Annual EBITDA
-$8.91 M
+$1.11 M+11.08%
December 31, 2023
Summary
- As of February 7, 2025, BDRX annual EBITDA is -$8.91 million, with the most recent change of +$1.11 million (+11.08%) on December 31, 2023.
- During the last 3 years, BDRX annual EBITDA has risen by +$19.61 million (+68.75%).
- BDRX annual EBITDA is now -66.08% below its all-time high of -$5.37 million, reached on December 1, 2016.
Performance
BDRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BDRX EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +11.1% | - | - |
3 y3 years | +68.8% | - | - |
5 y5 years | +35.6% | - | - |
BDRX EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -14.4% | +11.1% | ||||
5 y | 5-year | -14.4% | +68.8% | ||||
alltime | all time | -66.1% | +68.8% |
Biodexa Pharmaceuticals EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | -$8.91 M(-11.1%) | - | - |
Dec 2022 | -$10.02 M(+28.7%) | - | - |
Dec 2021 | -$7.79 M(-72.7%) | - | - |
Dec 2020 | -$28.52 M(+134.1%) | - | - |
Dec 2019 | -$12.18 M(-11.9%) | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2018 | -$13.83 M(+4.0%) | - | - |
Dec 2017 | -$13.30 M(+147.9%) | - | - |
Dec 2016 | -$5.37 M(-66.5%) | - | - |
Dec 2015 | -$16.03 M(+3.9%) | - | - |
Dec 2014 | -$15.42 M(+124.7%) | - | - |
Dec 2013 | -$6.87 M | - | - |
FAQ
- What is Biodexa Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals annual EBITDA year-on-year change?
What is Biodexa Pharmaceuticals annual EBITDA?
The current annual EBITDA of BDRX is -$8.91 M
What is the all time high annual EBITDA for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high annual EBITDA is -$5.37 M
What is Biodexa Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, BDRX annual EBITDA has changed by +$1.11 M (+11.08%)